| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.88B | 121.02B | 116.86B | 109.56B | 103.88B | 100.33B |
| Gross Profit | 46.93B | 46.49B | 44.88B | 42.11B | 40.10B | 39.26B |
| EBITDA | 15.19B | 15.06B | 14.27B | 13.47B | 12.12B | 13.19B |
| Net Income | 8.66B | 8.77B | 8.36B | 8.21B | 6.71B | 7.70B |
Balance Sheet | ||||||
| Total Assets | 118.15B | 127.23B | 120.81B | 109.63B | 103.54B | 99.49B |
| Cash, Cash Equivalents and Short-Term Investments | 28.21B | 30.01B | 29.54B | 26.42B | 23.68B | 22.59B |
| Total Debt | 3.10B | 4.20B | 4.95B | 4.22B | 5.09B | 4.61B |
| Total Liabilities | 21.96B | 31.23B | 31.50B | 27.27B | 27.59B | 27.36B |
| Stockholders Equity | 96.19B | 96.00B | 89.31B | 82.36B | 75.95B | 72.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.56B | 5.71B | 7.37B | 5.40B | 9.04B |
| Operating Cash Flow | 0.00 | 9.73B | 9.58B | 10.18B | 7.92B | 11.30B |
| Investing Cash Flow | 0.00 | -7.90B | -6.88B | -4.62B | -3.07B | -1.24B |
| Financing Cash Flow | 0.00 | -3.62B | -1.28B | -2.79B | -3.75B | -4.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥120.91B | 35.08 | ― | 3.57% | 3.00% | 5.43% | |
72 Outperform | ¥239.23B | 3.64 | 4.72% | 1.66% | 5.50% | -26.63% | |
70 Outperform | ¥25.89B | 10.21 | ― | 2.82% | 2.47% | 2.85% | |
69 Neutral | ¥6.16B | 9.76 | ― | 1.62% | 8.03% | 67.38% | |
64 Neutral | ¥378.10B | 11.50 | 5.53% | 4.35% | 22.07% | 86.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥641.48B | 5.81 | 7.44% | 2.10% | 5.58% | 114.23% |